Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cell therapies
cell therapies
ExCellThera announces new publication showing its ECT-001 cell therapy improves transplant access for all patients
BioSpace
Wed, 04/13/22 - 10:44 am
ExCellThera
ECT-001
cell therapies
cord blood
Allogene, broadening its reach, helps start a new biotech in China
BioPharma Dive
Tue, 12/15/20 - 10:47 am
Allogene
Overland Pharmaceuticals
China
cell therapies
Allogene Overland Pharma
AlloVir’s IPO Raises $276M to Test Cell Therapies in Transplant Patients
Xconomy
Thu, 07/30/20 - 11:20 pm
AlloVir
IPOs
cell therapies
organ transplant
Bayer-backed Century buys Empirica to create brain cancer CAR-Ts
Fierce Biotech
Tue, 06/23/20 - 11:01 am
Century Therapeutics
Empirica
cell therapies
brain cancer
glioblastoma
CAR-T
Fresh off ASCO myeloma data, Legend Bio gets $424M in biotech's biggest IPO of 2020
BioPharma Dive
Fri, 06/5/20 - 11:02 am
Legend Biotech
IPOs
cancer
cell therapies
ASCO 2020
J&J inks Fate deal to move into allogeneic CAR therapies
Fierce Biotech
Fri, 04/3/20 - 12:29 pm
JNJ
Fate Therapeutics
CAR NK
CAR-T
cell therapies
drug development
GSK pays $50M for 2 solid tumor cell therapies from Immatics
Pharmaceutical Business Review
Thu, 02/20/20 - 10:23 am
GSK
solid tumors
cell therapies
Immatics
Myeloma cell therapies, now in pharma hands, move into spotlight
Biopharma Dive
Sat, 12/7/19 - 11:47 pm
ASH2019
cell therapies
Multiple Myeloma
Bluebird Bio
Bristol-Myers Squibb
ide-cel
Celgene Adds Cell Therapies From Immatics With Bristol Sale in Sight
Xconomy
Wed, 08/28/19 - 10:55 am
Celgene
cell therapies
drug development
Immatics
cancer
Expensive Gilead, Novartis cancer therapies losing patients to experimental treatments
Yahoo/Reuters
Tue, 07/30/19 - 07:51 am
lymphoma
Gilead Siences
Novartis
cell therapies
Kymriah
Yescarta
Biotech’s newborn unicorn Sana grabs Harvard tech aimed at slipping engineered stem cells past the immune system
Endpoints
Tue, 03/26/19 - 11:13 pm
Sana Biotechnology
CAR-T
cell therapies
Harvard
Pluristem’s cell therapies head for orbit with NASA deal
Fierce Biotech
Wed, 02/20/19 - 10:12 am
Pluristem
NASA
cell therapies
Eli Lilly inks $63m deal with Sigilon to develop encapsulated cell therapies for diabetes
Drug Delivery Business News
Wed, 04/4/18 - 09:08 am
Eli Lilly
Sigilon
cell therapies
drug development
type 1 diabetes